Pages that link to "Item:Q4335625"
From MaRDI portal
The following pages link to Designed Extension of Studies Based on Conditional Power (Q4335625):
Displaying 50 items.
- A Bayesian adaptive design for two-stage clinical trials with survival data (Q745979) (← links)
- Inference of non-centrality parameter of a truncated non-central chi-squared distribution (Q1015893) (← links)
- Basic concepts of group sequential and adaptive group sequential test procedures (Q1580842) (← links)
- Robustness of sample size re-estimation with interim binary data for double-blind clinical trials (Q1765654) (← links)
- Procedures for testing multiple endpoints in clinical trials: an overview (Q1818602) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- Analysis of ``learn-as-you-go'' (LAGO) studies (Q2039787) (← links)
- Asymptotic properties of maximum likelihood estimators with sample size recalculation (Q2423166) (← links)
- Optimal two-stage group-sequential designs (Q2475735) (← links)
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials (Q2492935) (← links)
- On design and inference for two-stage adaptive clinical trials with dependent data (Q2492936) (← links)
- (Q2755673) (← links)
- Optimal adaptive two-stage designs for phase II cancer clinical trials (Q2858002) (← links)
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications (Q2875756) (← links)
- An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size (Q2927605) (← links)
- Internal pilots for observational studies (Q3056474) (← links)
- Sequential Methods in Multi-Arm Clinical Trials (Q3068083) (← links)
- On Sample Size and Inference for Two‐Stage Adaptive Designs (Q3078701) (← links)
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches (Q3078835) (← links)
- Monitoring Clinical Trials with Multiple Arms (Q3078836) (← links)
- Self-Designing Two-Stage Trials to Minimize Expected Costs (Q3078967) (← links)
- An Approach to the Conditional Error Rate Principle with Nuisance Parameters (Q3100810) (← links)
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs (Q3155694) (← links)
- Adaptive Design for Censored Survival Data Adjusting for Covariates (Q3430296) (← links)
- Are Flexible Designs Sound? (Q3436501) (← links)
- Optimal Conditional Error Functions for the Control of Conditional Power (Q3445294) (← links)
- Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials (Q3445330) (← links)
- Longitudinal clinical trials with adaptive choice of follow‐up time (Q3459945) (← links)
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials (Q3527716) (← links)
- Development of Adaptive Group Sequential Procedure for Changing Sample Size (Q3577219) (← links)
- Exact Confidence Bounds Following Adaptive Group Sequential Tests (Q3637002) (← links)
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs (Q4430337) (← links)
- THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL (Q4512641) (← links)
- ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER (Q4512838) (← links)
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
- Modification of Sample Size in Group Sequential Clinical Trials (Q4666658) (← links)
- Adaptive Sample Size Calculations in Group Sequential Trials (Q4668352) (← links)
- Interim Analysis and Sample Size Reassessment (Q4670476) (← links)
- Interim Design Modifications in Time-to-Event Studies (Q4916467) (← links)
- Probabilistic Foundation of Confirmatory Adaptive Designs (Q4916516) (← links)
- Adaptive Multivariate Global Testing (Q4975403) (← links)
- Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials (Q5050425) (← links)
- A note on the shape of sample size functions of optimal adaptive two-stage designs (Q5079909) (← links)
- A comparison between two treatments in a clinical trial with an ethical allocation design (Q5107007) (← links)
- <i>p</i>-Value calculation for multi-stage additive tests (Q5454212) (← links)
- Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang (Q5458022) (← links)
- Monitoring Continuous Long-Term Outcomes in Adaptive Designs (Q5460707) (← links)
- Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations (Q5714618) (← links)
- The Influence of Biostatistics at the National Heart, Lung, and Blood Institute (Q5885361) (← links)
- Sample size reassessment for a two-stage design controlling the false discovery rate (Q5962696) (← links)
